Clinical Trial Update: Efficacy of Co-administration of an NSAID With a Dopamine Agonist In Healthy Subjects [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy of co-administering an NSAID with a dopamine agonist in healthy subjects was withdrawn after initiation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Dopamine agonist
• NSAID (Non-steroidal anti-inflammatory drug)

Snippet

Sponsor: Northwestern University | Conditions: Acute Pain | Phase 2 | Status: WITHDRAWN